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Adapting to Climate Change
To the EditorDrPatz and colleagues1 raised concerns about the
adverse health effects of climate change. They reviewed the
evidenceon theeffects todateof the future risks fromachang-
ing climate and the opportunities for effective action to re-
duce risks.Although theauthorsurgedpublichealthprepared-
ness (adaptation) to climate change, there could be limits to
the effectiveness of adaptation.
Thepresent global burdenof disease fromclimate change
is relatively small, and it is often assumed that humanbeings’
capacity to adapt has no limits. Despite health being vulner-
able to thevagaries of climate, humanshaveadjusted their be-
havioral patterns and technologies to adapt to a diverse range
ofclimates.2However,projectedanthropogenicclimatechange
will pose new challenges that may be beyond existing coping
capacities.
Some extreme weather events have increased heat-
related illness and deaths. Changes in local temperature and
rainfall have altered the distribution of certain disease vec-
tors. Current public health practices, policies, and infrastruc-
ture may come under great pressure with the growing risk of
maladaptation.3
Recent assessments have identified an increased risk of
experiencing tipping points, and the corresponding effects
have been projected to be potentially catastrophic.4
Although there is little quantification of the adaptation
potential of public health associated with projected rates
and magnitudes of climate change, susceptible communi-
ties are already facing limits in their capacity to adapt to
existing climate variability.
Forexample, thehealthofpopulationsonsmall islandsand
in resource-poor countries has been shown to be particularly
vulnerable as a result of increasingexposure to severeweather
conditions.5 The reason for concern is that as global warming
accelerates, increasinglymorecommunitieswill approachtheir
adaptation limits.
The article by Patz et al1 demonstrates that responding to
and communicating the related health risks involves making
decisions in a changing climate with continuing uncertainty
about the timing and severity of the effects. Health profes-
sionalswill need to better understand the risks of doingnoth-
ing and the benefits to public health of undertaking appropri-
ate and timely action.
Cunrui Huang, MD, PhD
Roger Street, MS
Cordia Chu, PhD
Author Affiliations: School of Public Health, Sun Yat-sen University,
Guangzhou, China (Huang); Environmental Change Institute, University of
Oxford, Oxford, England (Street); Centre for Environment and Population
Health, Griffith University, Brisbane, Australia (Chu).
Corresponding Author: Cunrui Huang, MD, PhD, School of Public Health,
Sun Yat-sen University, 74 Zhongshan Rd, Guangzhou 510080, China
(huangcunrui@hotmail.com).
Conflict of Interest Disclosures: The authors have completed and submitted
the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were
reported.
1. Patz JA, Frumkin H, Holloway T, Vimont DJ, Haines A. Climate change:
challenges and opportunities for global health. JAMA. 2014;312(15):1565-1580.
2. McMichael AJ. Insights from past millennia into climatic impacts on human
health and survival. Proc Natl Acad Sci U S A. 2012;109(13):4730-4737.
3. Huang C, Vaneckova P, Wang X, Fitzgerald G, Guo Y, Tong S. Constraints and
barriers to public health adaptation to climate change: a review of the literature.
Am J Prev Med. 2011;40(2):183-190.
4. Lenton TM. Early warning of climate tipping points.Nat Clim Chang. 2011;1:201-
209.
5. Costello A, Abbas M, Allen A, et al. Managing the health effects of climate
change: Lancet and University College London Institute for Global Health
Commission. Lancet. 2009;373(9676):1693-1733.
In ReplyWeagreewithDrHuang and colleagues that there are
limits to human beings’ capacity to adapt to climate change,
especially if preventivemeasures arenot at the level of full so-
ciety, multisector interventions. Climate change is neither a
conventional single disease agent or toxic exposure nor an in-
dividual behavior that can be changed throughmedical tech-
nology or classic public health interventions. It represents a
risk that can undermine societal stability and disrupt life-
supporting natural resources.
We agree that large uncertainties exist in the capacity to
adapt in the faceof climateconditionsneverexperienced in the
past. Someunforeseenproblems for adaptationwereglimpsed
during the 2003 European heat wave. Extreme temperatures
meltedelectrical cables.Nuclearpowerplantsstruggledtokeep
reactors cool.1Manyadaptationmeasures that relyon technol-
ogy, such as air conditioning,may not be so dependable as the
mercury climbs to unprecedented levels.
We also agree regarding the urgency of actions on climate
change.Wedonot assume that adaptation to climate risks and
mitigationofclimate-alteringgreenhousegasemissionsshould
be a stepwise progression; our article concluded that curbing
fossil fuel combustion must occur quickly and at substantial
levels. For example, according to the Intergovernmental Panel
on Climate Change, to avoid heating the earthmore than 2°C,
by2050globalgreenhousegasemissionswouldneedtobe40%
to 70% lower than 2010 levels and emission levels near zero
by 2100.2
Although such policy measures may at first seem unreal-
istic, our analysis provided quantitative examples of very
large health co-benefits from mitigation of greenhouse
gases across at least 3 sectors: energy, transportation, and
food systems.
Cleaner energy strategies directed at short-lived climate
pollutantscouldavoidabout1millionto4milliondeathsworld-
wide annually by 2050by reducing fineparticulatepollution.3
In the United States, monetized human health benefits asso-
ciatedwith lower fineparticulate air pollutionexposures, par-
ticularlyby reducing coal burning, couldoffset the cost of low-
carbon policies by up to 10-fold.4 In otherwords, the value of
health dividends could swamp the costs of striving for an en-
ergy efficient, low-carbon economy.
Upward trends in noncommunicable diseases through-
out the world stem in part from sedentary lifestyles aided by
transportation systems designed for automobile-dependent
travel and from diets high in animal products and low in veg-
etables and fruit. So in addition to air quality improvements,
there are more opportunities for public health through the
adoption of alternative modes of transportation, especially
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those that promote active transport by foot or bicycle, along-
side effective public transportation, and through the promo-
tion of more healthful diets.
In summary, increasing trends in noncommunicable dis-
eases in parallel to increasing rates of fossil fuel–based en-
ergy consumption that are disrupting the earth’s climate pre-
sent daunting risks to civilization. Yet the interdependence of
these challenges affords a goldenopportunity to solveboth si-
multaneously. Action must not be delayed.
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Goals of DisplayingHealth Care Prices to Physicians
To the Editor The price of medical care is an essential compo-
nent in the assessment of value. Drs Riggs and DeCamp1 dis-
cussed concerns about the display of price to physicians. The
discussion is confounded when expanded to the goal of in-
forming patients and ensuring fairness.
The key stakeholder in the assessment of the value of
health care services is the patient. The physician’s role as ex-
pert is to recommend the most cost-effective evaluation and
management strategy. The authors’ initial question of which
price is right reflects that perspective.
The goals of price transparency for physicians and pa-
tientsdiffer.Thegoalofpriceprovision to thephysicianshould
be to inform his or her recommendation of the most cost-
effective testsorprocedures. Somemedical societieshavepro-
vided appropriateness criteria for various tests that incorpo-
rate cost andoutcomes.For thisuse, the indicationof anactual
dollar amount is unnecessary; the use of price indicators (eg,
$, $$, $$$) rather than actual prices can provide the aspect of
price relevant to a physician’s decision to recommend a par-
ticular test or procedure.
In discussion with a particular patient, however, the ac-
tual charges are pertinent. The authors suggested that if a pa-
tient is less well insured, the display of the price may de-
crease thechanceofhimorher receivinga test (comparedwith
an insured patient) and therefore be unfair. This would only
beunfair if thedecision ismadeby thephysician alone, rather
than in consultation with the patient.
If thepatientdeclinesa recommendedaspectof carebased
on theprice, thismaybeunfair, but it is an inappropriate criti-
cism of price transparency. Because individuals in the popu-
lation have various levels of wealth and insurance coverage,
the process of shared decisionmaking can onlymaximize pa-
tient-centered value in the setting of their individual means
and the bills they will confront.
Differential pricing may be unfair, but it reflects the un-
derlying unfairness of the distribution of wealth and insur-
ance coveragewithin thepopulation;makingprices transpar-
ent is not unfair.
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In Reply We agree with Dr Hoffer that prices are an essential
component in assessing value and in general have no objec-
tion to theuseofpricedisplays.Rather,weargued inourView-
point that since different displayed “prices” (eg, hospital list
price vsMedicare fee amount)might differentially affect phy-
sicianbehavior, it is important to considerhowdifferentprices
might operate in practice and weigh the ethical implications
of each.
We also agree that patients are arguably the most impor-
tant stakeholder when assessing value and that physicians
should engage with patients in discussing the out-of-pocket
costs associated with their care.1 However, in some circum-
stances, robust shared decision making may not be possible.
For example, patients in acute care hospitals or intensive care
units may be unable or uninterested in weighing cost trade-
offs. Ina recent surveyofhospitalizedpatients,more than70%
indicated that they preferred to leave medical decision mak-
ing to their physician.2
Uncertainty over the status of patients’ deductibles, co-
insurance, and eventual out-of-pocket responsibilities fur-
ther complicates truly informed shareddecisionmaking.Rec-
ognizing that at least some price displays will operatemainly
at the physician level, our intent was to bring attention to the
ethical considerations involved, such as transparency, pro-
tecting patient well-being, and ensuring fairness.
Hoffermakes anovel suggestion that general indicators of
price (eg, displaying $ vs $$ vs $$$) could suffice to inform
value-based decision making. Particularly if small variations
in price (such as displaying $30 vs $40 for a chest radiograph)
do not affect physician behavior, we agree such strategies are
simpler andworth exploring.However,whenpotential prices
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